Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING
STI
Active
Org 930517364
Sørkedalsveien 6, 0369
Oslo
Activities of other membership organisations n.e.c.
· NACE 9499
Est. 2022 · 3 years old
0 employees
www.unifor.no
Monitor
Share
Norway
/
Companies
/
Activities of other membership organisations n.e.c.
/
BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
EBITDA
NOK millions
0M
-1M
-1M
-2M
-3M
-1M
2023
-2M
-100%
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
523
1 684
Staff expenses
−0
−0
EBITDA
−542
−1 697
Depreciation & amort.
−0
−0
EBIT
−542
−1 697
Net financials
−50
1
Profit before tax
−592
−1 697
Tax
−0
−0
Net profit
−592
−1 697
Balance sheet
NOK thousands
Item
2023
2024
Total assets
2 018
321
Equity
2 018
321
Long-term debt
0
0
Short-term debt
0
0
Total debt
0
0
Financial ratios
5-year trend
EBITDA margin
-100.8%
This company
15.8%
Market median
-738% vs market
2023
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2023
2024
Return on equity
-528.3%
This company
18.4%
Market median
-2971% vs market
2023
2024
Net profit margin
-100.8%
This company
8.1%
Market median
-1344% vs market
2023
2024
Asset turnover
5.24×
This company
1.12×
Market median
+368% vs market
2023
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-11-24 – 2023-12-31
View
PDF
More on BJARNE BOGENS STIFTELSE TIL FREMME AV IMMUNOLOGISK FORSKNING
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
